June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Flavoprotein Fluorescence (FPF) Elevation Using Retinal Metabolic Analysis Correlates with Decreased Visual Acuity in Patients with Various Retinal Pathologies
Author Affiliations & Notes
  • Sofia Ahsanuddin
    Medical Education, Icahn School of Medicine at Mount Sinai, New York, New York, United States
    Ophthalmology, New York Eye and Ear Infirmary of Mount Sinai, New York, New York, United States
  • Oscar Otero-Marquez
    Ophthalmology, New York Eye and Ear Infirmary of Mount Sinai, New York, New York, United States
  • Collin Rich
    OcuSciences Inc., Ann Arbor, Michigan, United States
  • Richard B Rosen
    Ophthalmology, New York Eye and Ear Infirmary of Mount Sinai, New York, New York, United States
    Ophthalmology, Icahn School of Medicine at Mount Sinai, New York, New York, United States
  • Footnotes
    Commercial Relationships   Sofia Ahsanuddin None; Oscar Otero-Marquez None; Collin Rich OcuSciences, Code E (Employment), OcuSciences, Code I (Personal Financial Interest); Richard Rosen OptoVue, Boehringer-Ingelheim, Code C (Consultant/Contractor), OptoVue, OcuSciences, Topcon, Code F (Financial Support), Opticology, Guardion, Code I (Personal Financial Interest), OptoVue, Code P (Patent)
  • Footnotes
    Support  This study was supported by the National Eye Institute of the National Institutes of Health under award number R01EY027301. Additional funding for this research was provided by the New York Eye and Ear Infirmary Foundation Grant, the Marrus Family Foundation, and the Jorge N. Buxton Microsurgical Foundation.
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 3515. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Sofia Ahsanuddin, Oscar Otero-Marquez, Collin Rich, Richard B Rosen; Flavoprotein Fluorescence (FPF) Elevation Using Retinal Metabolic Analysis Correlates with Decreased Visual Acuity in Patients with Various Retinal Pathologies. Invest. Ophthalmol. Vis. Sci. 2022;63(7):3515.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Oxidative stress linked to mitochondrial dysfunction is implicated in the pathophysiology of several retinal pathological conditions. Previous studies have shown that retinal flavoprotein fluorescence (FPF) can be used as a potential biomarker for oxidative stress. Herein, we hypothesize that FPF is higher in conditions mediated by oxidative stress and inversely correlates with best corrected visual acuity (BCVA).

Methods : 10 eyes from 10 healthy subjects, 3 eyes from 3 central serous retinopathy (CSR) patients, 8 eyes from 8 retinal vein occlusion (RVO) patients, 6 eyes from 6 proliferative diabetic retinopathy (PDR) patients, and 12 eyes from 12 chronic exudative age-related macular degeneration (AMD) patients were included in the present observational study (n=39). Eyes were imaged non-invasively using a specialized fundus camera OcuMet Beacon (OcuSciences, Ann Arbor, MI). During each imaging session, the macula was imaged with a blue light in the narrow emission spectra from 520 to 540 nm. Kruskal-Wallis tests were performed to assess differences in FPF values and BCVA between the five groups. Spearman rank correlation coefficient was calculated to assess the relationship between FPF and BCVA. A p < 0.05 was considered to be statistically significant.

Results : FPF values and BCVA of all five groups differed significantly (Kruskal-Wallis Tests, p < 0.001 and p = 0.003, respectively). Mean FPF values of healthy controls, CSR, RVO, PDR, and wet AMD patients were 29.5 ± 7.8, 51 ± 15.6, 60.7 ± 24.4, 64 ± 25.7, and 65 ± 17.7, respectively. Compared to healthy controls, FPF values were significantly higher in conditions such as RVO, PDR, and wet AMD (p = 0.010, p = 0.012, and p < 0.01, respectively). In contrast, there was no significant difference between FPF values of CSR patients compared to healthy controls (p = 0.912). There was an inverse correlation between FPF values and BCVA (r = -0.547, p < 0.01).

Conclusions : FPF values were significantly greater in diseases known to be mediated by oxidative stress compared to healthy controls. Higher FPF values were seen in conditions such as RVO, PDR, and wet AMD as compared to CSR, indicating that there may be varying degrees of oxidative stress in these conditions. The data is consistent with previously published literature on FPF being inversely correlated with BCVA.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×